Virtual open house at our sites in Vancouver and Birmingham

Overview

We warmly invite you to join a virtual open house at our sites in Vancouver (Canada) and Birmingham (USA). Even in times of COVID-19, we stand for an open and approachable culture. With this virtual open house event, we would like to give you the opportunity to get to know our Vancouver and Birmingham facilities where we help customers develop, manufacture and fill complex parenteral drug products.

In this interactive event, you'll learn about:

Our parenteral drug delivery solutions portfolio
Birmingham and Vancouver facilities and full services for injectable drug product filling lines
Vancouver Laboratories’ facilities and capabilities for lipid-based drug delivery solutions
Birmingham Laboratories’ facilities and capabilities for complex parenteral manufacturing and filling

As a fully integrated CDMO, we can support customers from early-stage development to commercial-scale cGMP production and are more than happy to introduce you to our facilities more in-depth.

At the end of the virtual open house our experts will answer your questions live. You will have the chance to submit your questions through the event chat and in different languages (English, Japanese, Korean).

Experts featuring this session

Dr. Jay Natarajan
Director of Technical Business Development and Marketing APAC
Evonik Health Care
Vita

Dr. Natarajan holds a Ph.D. from Nanyang Technological University (NTU) in Singapore and was previously the head of the R&D group at Evonik Vancouver Laboratories.

Jay is currently serving as the Director of Technical Business Development and Marketing for the Asia Pacific region and is based in Singapore.

He started his professional career with Sun Pharma and was instrumental in the commercial scale up of LipoDox.

Thereafter, he held various positions with different centers and institutes of NTU albeit his focus always revolved around the research and development of nanomedicines, particularly lipid nanoparticles.

Jay is the author of ten peer-reviewed papers and an inventor on two patents.

Natalia Zisman
Senior Manager Technical Marketing
Evonik Health Care
Vita

Natalia Zisman is a Manager of Process Development at Evonik Vancouver Laboratories, specializing in liposome and lipid nanoparticle drug delivery systems. She is responsible for facilitating technology transfer of customer projects from R&D to clinical manufacturing. Natalia has 20 years of experience in liposome/lipid nanoparticle drug delivery field and has worked in a number of local drug delivery companies prior to joining Evonik in 2014. She has been involved in all aspects of liposome manufacturing, starting from early stage formulation design, process development, scale-up and clinical manufacturing. Natalia holds undergraduate degree in Chemistry from University of British Columbia.

Jane Meyer
Global Head Parenteral Services
Evonik Health Care
Vita

Jane M. Meyer holds a MSc in Organic Chemistry, Master’s in Management, Merger & Acquisition Advisor as well as studied law.

Jane has experience as successful entrepreneur and spent most of her 30+ year career in pharmaceutical, scientific, and business development roles for CDMO companies supporting both drug substances and drug products (Sterile manufacturing, LNPs RNA, ADCs, Pegylated compounds, Small molecules, Peptides, Biologics, etc.).

Jane is the Global Head of Parenteral Services for Evonik.

Dr. Maaike Everts
Director Strategic Marketing Parenteral Drug Delivery Solutions
Evonik Health Care
Vita

Maaike Everts joined Evonik as a senior project manager in 2019 before taking on a role as director of strategic marketing.

Prior to this Maaike was a full professor in the School of Medicine at the University of Alabama at Birmingham (UAB) in the U.S., where she had leadership roles in the Alabama Drug Discovery Alliance, a venture between UAB and Southern Research, and the Antiviral Drug Discovery and Development Consortium.

Maaike obtained her PhD in pharmacokinetics and drug delivery from the University of Groningen, The Netherlands, which was followed by postdoctoral training in gene therapy at (UAB).